The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 37 | 105.5x | 20.1x | Near average | |
Growth | 34 | 9.5% | 5.6% | Near average | |
Quality | 65 | -227.9% | 7.6% | Near average | |
Safety | 69 | -0.1x | 0.4x | Above average | |
Capital Return | 38 | 3.10% | 2.19% | Near average | |
Momentum | 50 | — | — | Near average | |
Sentiment | 51 | — | — | Near average |
AbbVie Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy AbbVie Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analyst reviews for AbbVie stock have shown positive stability over the past month, with the average price target rising by 0.46% to reach $257.54, while the current price (215.7) remains below the lowest conservative forecast ($223). This price gap indicates institutional optimism regarding a growth opportunity, supported by the confirmation of 'Overweight' ratings by major institutions such as Morgan Stanley and Piper Sandler during the current quarter.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.